INTERNATIONAL PATENT: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION, 사회복지법인 삼성생명공익재단, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, 서울대학교산학협력단 FILES APPLICATION FOR "BIOMARKER FOR PREDICTING THERAPEUTIC RESPONSIVENESS TO ORAL IMMUNOTHERAPY IN PEDIATRIC PATIENTS WITH FOOD ALLERGIES AND METHOD FOR PREDICTING THERAPEUTIC RESPONSIVENESS TO ORAL IMMUNOTHERAPY USING SAME"

GENEVA, April 14 -- SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (48, Itaewon-ro 55-gilYongsan-guSeoul 04348), 사회복지법인 삼성생명공익재단 (서울특별시용산구이태원로55길 48), SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (1 Gwanak-roGwanak-guSeoul 08826), 서울대학교산학협력단 (서울특별시관악구관악로 1) filed a patent application (PCT/KR2024/015210) for "BIOMARKER FOR PREDICTING THERAPEUTIC RESPONSIVENESS TO ORAL IMMUNOTHERAPY IN PEDIATRIC PATIENTS WITH FOOD ALLERGIES...